These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17493078)

  • 1. Ultraviolet B exposure could influence the interpretation of serum S100beta levels in patients with malignant melanoma.
    Vitzthum J; Dörr HD; Meineke V
    Br J Dermatol; 2007 Apr; 156(4):772-3. PubMed ID: 17493078
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D; Chiriboga L; Rubin BP
    Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary malignant melanoma of the rectum arising against a background of rectal melanosis.
    Righi A; Dimosthenous K
    Int J Surg Pathol; 2008 Jul; 16(3):335-6. PubMed ID: 18573790
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.
    Helfrich I; Edler L; Sucker A; Thomas M; Christian S; Schadendorf D; Augustin HG
    Clin Cancer Res; 2009 Feb; 15(4):1384-92. PubMed ID: 19228739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
    Nonaka D; Chiriboga L; Rubin BP
    J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
    Bolander A; Agnarsdóttir M; Wagenius G; Strömberg S; Pontén F; Ekman S; Brattström D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M
    Melanoma Res; 2008 Dec; 18(6):412-9. PubMed ID: 19011512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How far can we trust cell cycle biomarkers for the identification of high-risk melanoma patients?
    Simonart T; Heenen M
    J Cutan Pathol; 2005 May; 32(5):383-4. PubMed ID: 15811127
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2007 Dec; 29(6):566-7. PubMed ID: 18032954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new piece in the melanoma mosaic--carcinosarcoma-like melanoma.
    Svec A; Wilkinson L; Bury Y; Martin VG
    Histopathology; 2009 Sep; 55(3):366-8. PubMed ID: 19723157
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.
    Egberts F; Pollex A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
    Onkologie; 2008 Jul; 31(7):380-4. PubMed ID: 18596385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A firm red-brown plaque on the arm. Dermatofibrosarcoma protuberans(DFSP), pigmented variant (Bednar tumor.
    Quigley EA; Marghoob AA; Busam KJ; Chen CS
    Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451510
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic value of c-myc oncoprotein levels in malignant melanoma.
    Ekwobi CC
    J Plast Reconstr Aesthet Surg; 2008; 61(4):464. PubMed ID: 18249164
    [No Abstract]   [Full Text] [Related]  

  • 17. S100 A6 immunohistochemical staining for spindle cell and desmoplastic melanomas.
    Puri PK; Forman SB; Ferringer T; Elston D
    J Cutan Pathol; 2008 Feb; 35(2):256-7. PubMed ID: 18190457
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine-needle aspiration biopsy of metastatic malignant melanoma resembling a malignant peripheral nerve sheath tumor.
    Bardarov S; Michael CW; Lucas D; Pang Y; Pu RT
    Diagn Cytopathol; 2008 Oct; 36(10):754-7. PubMed ID: 18773432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in prognostication of cutaneous malignant melanoma.
    Penmatcha S; Rovinsky SA; Cockerell CJ; Hsu MY
    Adv Dermatol; 2004; 20():323-43. PubMed ID: 15544206
    [No Abstract]   [Full Text] [Related]  

  • 20. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.